Skip to main content
Figure 1 | Malaria Journal

Figure 1

From: Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults

Figure 1

Subject disposition in study 1134 (A) and study 1155 (B). aThe AZCQ 500-mg regimen was not included in the analysis, as treatment was stopped early on the recommendation of the data safety monitoring board after a review of data from studies conducted in South America and India demonstrated a dose response with lower efficacy rates for this regimen compared with AZCQ 1,000 mg. AE, adverse event; AZCQ 1,000 mg, azithromycin 1,000 mg plus chloroquine 600-mg base; AZCQ 500 mg, azithromycin 500 mg plus chloroquine 600-mg base; MQ, mefloquine hydrochloride; PP, per protocol.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us